Abstract: According to one embodiment, an automatic analyzing apparatus includes a probe and a liquid level detector. The liquid level detector is electrically connected to the probe and detects contact between the probe and a liquid surface, wherein the liquid level detector comprises an adjuster configured to adjust electrostatic capacitance of one or more capacitors for circuitry for use in liquid level detection.

Abstract: An energy storage device includes an electrode body and an outer packaging. The outer packaging seals the electrode body. The outer packaging is constituted by a film-like outer packaging member. The outer packaging includes a first sealing portion sealed by joining surfaces that face each other in a state in which the outer packaging member is wrapped around the electrode body. A base portion of the first sealing portion is formed at the boundary between a first surface and a second surface of the outer packaging. The first surface has a larger area than the second surface. The first sealing portion does not overlap the first surface in a plan view.

Abstract: A drive device includes an electric motor and a control unit which are integrated together. The control unit is configured to control the electric motor by using an electric power supply and a signal supplied through an external cable. The control unit includes: a parent circuit board, which is installed to the electric motor; and a connector module, which is configured to connect the parent circuit board to an external connector of the external cable. The connector module includes: a connector portion that is configured to be coupled with and decoupled from the external connector; a wiring module that is configured to receive the electric power supply and the signal from the external cable through the connector portion; and a plurality of connecting conductors that electrically connect the wiring module to the parent circuit board.

Abstract: A first buffer fluid containing a first bead having fixed to a surface thereof a first antibody that specifically binds to a first antigen is injected into a reaction container, and then a plurality of a second bead having fixed to a surface thereof a second antibody that specifically binds to an optional second antigen, and a biological sample containing an exosome to be analyzed having the first antigen and the second antigen on a surface of the exosome are injected into the reaction container, thereby generating a second buffer fluid. An exosome having the first bead and the second bead bound thereto is collected from the second buffer fluid. The exosome having the first bead and the second bead bound thereto is separated into the first bead, the second bead, and the exosome, and the second bead and the exosome are individually collected.

Abstract: An electronic device includes: a wiring board; an electric connection wiring connected to a power supply; motor connection wirings arranged on a peripheral side of the wiring board and connected to the electric motor; and semiconductor modules having semiconductor elements and a resin mold. The semiconductor modules are arranged at a position on the electric connection wiring or on the peripheral side of the electric connection wiring and on a center side of the motor connection wiring. At least a part of electrodes of the plurality of semiconductor modules is mounted on the electric connection wiring.

Abstract: A semiconductor module includes: semiconductor elements having a gate electrode, a first electrode and a second electrode; a resin mold; and conductive members connected to at least one of the semiconductor elements and having a common wiring electrode exposed from the resin mold and connected to the first electrode or the second electrode and a non-common wiring electrode exposed from the resin mold and connected to an electrode of the semiconductor element different from the common wiring electrode. A width of a common wiring connected to the common wiring electrode is wider than the non-common wiring electrode. The common wiring is arranged from one side to an opposite side on a surface of the resin mold, on which the common wiring electrode is exposed, without being electrically connected to the non-common wiring electrode.

Abstract: A metal member producing device includes a spindle, a base portion, and a driving portion which drives at least one of the spindle and the base portion in an axial direction of the spindle. Of the spindle and the base portion, one includes a first holding portion for holding a first member. The other has disposed thereon a mold for holding a second member to oppose the first holding portion. The mold includes a bottom wall and a sidewall that extends from the bottom wall in a direction intersecting the bottom wall. The sidewall has a resistive wall formed thereon, the resistive wall being a wall surface inclined with respect to a plane parallel to the axial direction of the spindle so as to face the bottom wall side.

Abstract: A set of fishline guides which are configured to be attached to a rod in an axial direction of the rod, each of the set of fishline guides includes a frame including a fixing portion configured to be attached to an outer surface of the rod, a ring holding portion to which a guide ring through which a fishline passes is attached, and a support leg connecting the fixing portion to the ring holding portion, the fixing portion being in a plane transverse to a plane of the ring holding portion. The frame includes a plurality of fiber-reinforced resin layers foamed by laminating a plurality of fiber-reinforced prepregs in which a reinforcing fiber is impregnated with a synthetic resin. A normal line to a plane of each of the fiber-reinforced resin layers forming the ring holding portion coincides with an axial direction of the ring holding portion.

Abstract: A metal member producing device includes a spindle, a base portion, and a driving portion which drives at least one of the spindle and the base portion in an axial direction of the spindle. Of the spindle and the base portion, one includes a first holding portion for holding a first member. The other has disposed thereon a mold for holding a second member to oppose the first holding portion. The mold includes a bottom wall and a sidewall that extends from the bottom wall in a direction intersecting the bottom wall. The sidewall has a resistive wall formed thereon, the resistive wall being a wall surface inclined with respect to a plane parallel to the axial direction of the spindle so as to face the bottom wall side.

Abstract: An oral stain remover which can remove a stain or a dental plaque effectively without a need of brushing the surface of teeth with a toothbrush or the like, and an oral composition containing the stain remover. An oral stain remover contains a salt of ultraphosphoric acid, and an oral composition contains the oral stain remover.

Abstract: A vibration-proof structure for an electric circuit for use in an inverter-integrated electric compressor can reduce cost and weight of the compressor and can have excellent productivity. The vibration-proof structure for the electric circuit of the electric compressor for use in a vehicle air conditioner, the compressor integrally including a motor for driving a compression mechanism and an electric circuit which controls drive of the motor, the structure being characterized in that an assembly 26, which is obtained by mounting at least one electric component requiring a vibration-resistant reinforcement (a coil and a capacitor constituting a noise filter, and a smoothing capacitor) on a dedicated circuit board 24 and by embedding the electric component with resin 25, is assembled in a housing of the compressor. Thus, resin consumption can be greatly reduced, cost and weight of the compressor can be reduced, and productivity can be improved.

Abstract: Novel amine compounds which are represented by the following formula (1) and efficacious against diseases such as a viral infectious disease with HIV, rheumatism, and cancer metastasis; typically, A1 and A2 represent a hydrogen atom or a substitutable monocyclic or polycyclic heteroaromatic ring and W represents a substitutable benzene ring or any group represented by the following formula (10) or (11): where X represents O, CH2, C(?O), NR11, or CHR35 and D represents a group represented by the following formula (6): [Formula 4] -Q-Y—B??(6) where Q represents a single bond, NR12, or a group represented by the formula (13): and Y represents a group represented by the following formula (7): [Formula 6] —(CR18R19)m3- or —(CR20R21)m4-z-(CR22R23)m5-??(7) where z represents a substitutable monocyclic or polycyclic aromatic ring; and B represents —NR25R26; and R1 to R26 in the above formulae represent a hydrogen atom, an alkyl group, an alkenyl group, or an alkynyl group.

Abstract: Amine compounds represented by Formula (1) are efficacious against diseases such as a viral infectious disease with HIV, rheumatism, and cancer metastasis:

Abstract: It is intended to provide novel amine compounds which are efficacious against diseases such as infection with HIV virus, rheumatism and cancer metastasis. Namely, amine compounds represented by the following general formula (1): In a typical case, A1 and A2 represent each an optionally substituted monocyclic or polycyclic aromatic heterocycle; W represents cyclic C3-10 alkylene, an optionally substituted monocyclic or polycyclic aromatic heterocycle, a monocyclic or polycyclic aromatic ring or a partly saturated polycyclic aromatic ring; X represents O, CH2, C(?O) or NR11; and D is a group represented by the following general formula (4) or (6). In the formula (6), Q represents a single bond, S, O or NR12; and Y is a group represented by the following general formula (7). —(CR18R19)m3— Or —(CR20R21)m4-z-(CR22R23)m5??(7) z represents an optionally substituted monocyclic or polycyclic aromatic ring. In the formula (6), B represents NR25R26.

Abstract: It is intended to provide novel amine compounds which are efficacious against diseases such as infection with HIV virus, rheumatism and cancer metastasis. Namely, amine compounds represented by the following general formula (1): In a typical case, A1 and A2 represent each an optionally substituted monocyclic or polycyclic aromatic heterocycle; W represents cyclic C3-10 alkylene, an optionally substituted monocyclic or polycyclic aromatic heterocycle, a monocyclic or polycyclic aromatic ring or a partly saturated polycyclic aromatic ring; X represents O, CH2, C(?O) or NR11; and D is a group represented by the following general formula (4) or (6). In the formula (6), Q represents a single bond, S, O or NR12; and Y is a group represented by the following general formula (7). z represents an optionally substituted monocyclic or polycyclic aromatic ring. In the formula (6), B represents NR25R26. In the above formulae, R1 to R26 each represents hydrogen, alkyl, alkenyl or alkynyl.

Abstract: An oral stain remover which can remove a stain or a dental plaque effectively without a need of brushing the surface of teeth with a toothbrush or the like, and an oral composition containing the stain remover. An oral stain remover contains a salt of ultraphosphoric acid, and an oral composition contains the oral stain remover.

Abstract: Novel amine compounds which are represented by the following formula (1) and efficacious against diseases such as a viral infectious disease with HIV, rheumatism, and cancer metastasis; typically, A1 and A2 represent a hydrogen atom or a substitutable monocyclic or polycyclic heteroaromatic ring and W represents a substitutable benzene ring or any group represented by the following formula (10) or (11): where X represents O, CH2, C(?O), NR11, or CHR35 and D represents a group represented by the following formula (6): where Q represents a single bond, NR12, or a group represented by the formula (13): and Y represents a group represented by the following formula (7): where z represents a substitutable monocyclic or polycyclic aromatic ring; and B represents —NR25R26; and R1 to R26 in the above formulae represent a hydrogen atom, an alkyl group, an alkenyl group, or an alkynyl group.

Abstract: It is intended to provide novel amine compounds which are efficacious against diseases such as infection with HIV virus, rheumatism and cancer metastasis. Namely, amine compounds represented by the following general formula (1): In a typical case, A1 and A2 represent each an optionally substituted monocyclic or polycyclic aromatic heterocycle; W represents cyclic C3-10 alkylene, an optionally substituted monocyclic or polycyclic aromatic heterocycle, a monocyclic or polycyclic aromatic ring or a partly saturated polycyclic aromatic ring; X represents O, CH2, C(?O) or NR11; and D is a group represented by the following general formula (4) or (6). In the formula (6), Q represents a single bond, S, O or NR12; and Y is a group represented by the following general formula (7). z represents an optionally substituted monocyclic or polycyclic aromatic ring. In the formula (6), B represents NR25R26. In the above formulae, R1 to R26 each represents hydrogen, alkyl, alkenyl or alkynyl.

Abstract: Novel amine compounds which are efficacious against diseases such as infection with HIV virus, rheumatism, and cancer metastasis include compounds represented by the following general formula (1), a pharmacologically acceptable salt thereof, or a prodrug thereof: wherein each of n1, n2, and n3 is an integer of 1; each of R1, R2, R3, R4, R5, and R6 is independently a hydrogen atom; A1 is imidazole; A2 is imidazole or imidazole substituted with an alkyl group; W is a phenyl group or naphthyl group; X is CH2; D is a group represented by -Q-Y—B, wherein Q is NR12 and R12 is a hydrogen atom or an alkyl group; Y is (CH2)m3 and m3 is an integer of 2 to 4; and B is N(R25R26), wherein each of R25 and R26 are independently a hydrogen atom, a C1–C6 alkyl group or a C3–C6 cycloalkyl group.

Abstract: It is intended to provide novel amine compounds which are efficacious against diseases such as infection with HIV virus, rheumatism and cancer metastasis. Namely, amine compounds represented by the following general formula (1): In a typical case, A1 and A2 represent each an optionally substituted monocyclic or polycyclic aromatic heterocycle; W represents cyclic C3-10 alkylene, an optionally substituted monocyclic or polycyclic aromatic heterocycle, a monocyclic or polycyclic aromatic ring or a partly saturated polycyclic aromatic ring; X represents O, CH2, C(?O) or NR11; and D is a group represented by the following general formula (4) or (6). In the formula (6), Q represents a single bond, S, O or NR12; and Y is a group represented by the following general formula (7). z represents an optionally substituted monocyclic or polycyclic aromatic ring. In the formula (6), B represents NR25R26. In the above formulae, R1 to R26 each represents hydrogen, alkyl, alkenyl or alkynyl.